Cutera, Inc. (NASDAQ:CUTR) medical appliance manufacturer, is expected to report third quarter earnings results, after market close, on Wednesday 4th November 2020.
Analysts polled by Thomson Reuters anticipate third quarter loss of $ 0.33 per share.
Looking ahead, the full year loss are expected at $ 1.16 per share on the revenues of $ 139.21 million.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 194.00 million ~ $ 200.00 million
Click Here For More Historical Outlooks Of Cutera, Inc.
Previous Quarter Performance
Cutera, Inc. communicated loss for the second quarter of $ 0.23 per share, from the revenue of $ 26.37 million. The quarterly revenues declined 44.80 percent compared with the same quarter last year. Street analysts expected Cutera, Inc. to report loss of $ 0.63 per share on revenue of $ 20.69 million for the second quarter. The bottom line results beat street analysts by $ 0.4 or 63.49 percent, at the same time, top line results outshined analysts by $ 5.68 million or 27.45 percent.
Stock Performance
Shares of Cutera, Inc. traded up $ 0.90 or 4.61 percent on Tuesday, reaching $ 20.44 with volume of 81.40 thousand shares. Cutera, Inc. has traded high as $ 20.92 and has cracked $ 19.65 on the downward trend
According to the previous trading day, closing price of $ 20.44, representing a 115.44 % increase from the 52 week low of $ 9.07 and a 50.09 % decrease over the 52 week high of $ 39.15.
The company has a market capital of $ 359.62 million and is part of the Healthcare sector and Medical Devices industry.
Recent Analyst recommendations
- On 30th September 2020, maintained by Piper Sandler at Overweight rating, with $ 22.00 target price.
Conference Call
Cutera, Inc. will be hosting a conference call at 4:30 PM eastern time on 4th November 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.cutera.com
Cutera, Inc., a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating. It also provides excel V, a vascular and benign pigmented lesion treatment platform; xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity; Juliet, a laser system for vaginal health; and Secret RF, a fractional radio frequency microneedling device for skin revitalization.
